People
The news was disclosed by Ruyi He, MD, Chief Scientist of the CFDA and the Center for Drug Evaluation.
In the world of Alzheimer’s disease research, the names of some companies attempting to find an efficacious therapy stand out.
A federal judge has temporarily blocked the Trump administration’s efforts to wind down DACA.
MiMedx’s problems with short sellers continues.
Teva has made a target of cutting costs by $3B by the end of 2019.
Novartis has found its new chief of oncology.
In his opening presentation at JPM, he highlighted one major product to show how the Irish medtech company is pursuing value-based care.
The financing was co-led by Advantech Capital and SDIC Venture Capital.
It is not clear what the new company’s focus is just yet.
The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners.
PRESS RELEASES